| Name | [2-butyl-5-chloro-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol |
|---|---|
| Synonyms |
Lostan N1-Trityl Impurity
[phenyl-(phenylthio)sulfonyl-methyl]benzene Enalapril IMpurity H N-Trithyl Lostan 2-Butyl-4-chloro-1-[(2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl]-1H-imidazol-5-yl]methanol Allistan Isoproxil INT N-Trityl Lostan Trityllostan Discontinued, not on 2 position 2-Butyl-4-chloro-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl-4-yl]Methyl]-1H-iMidazole-5-Methanol Trityllosartan N-Trityl Losartan (2S)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycbonyl)propyl] amino]propanoyl]pyrrolidine-2-cboxylic acid (2-BUTYL-4-CHLORO-1-((2'-(1-TRITYL-1H-TETRAAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-1H-IMIDAZOL-5-YL)METHANOL 2-N-Butyl-4-Chloro-5-Hydroxymethyl-1-[[2’(1H-2-Triphenylmethyl-Tetrazol-5-Yl)Biphenyl-4-Yl]Methyl]Imidazole (2-Butyl-4-chloro-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazol-5-yl)methanol [phenyl(phenylsulfanylsulfonyl)methyl]benzene Enalapril IMpurity H (Mixture of IsoMers) (2-Butyl-4-chloro-1-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-5-yl)methanol [2-Butyl-4-chloro-1-[[2'-[2-(triphenylMethyl)-2H-tetrazol-5-yl]biphenyl-4-yl]Methyl]-1H-iMidazol-5-yl]Methanol Losaint-D N1-Trityl Lostan 2-Butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-2-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazole Lostan N-Trithyl Impurity 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl] |
| Density | 1.225g/cm3 |
|---|---|
| Boiling Point | 856.623ºC at 760 mmHg |
| Molecular Formula | C41H37ClN6O |
| Molecular Weight | 665.22500 |
| Flash Point | 471.868ºC |
| Exact Mass | 664.27200 |
| PSA | 81.65000 |
| LogP | 8.58040 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 1.656 |
|
~%
124751-00-4 |
| Literature: US2004/97568 A1, ; Page/Page column 5 ; |
|
~46%
124751-00-4 |
| Literature: US5128355 A1, ; US 5128355 A |
|
~%
124751-00-4 |
| Literature: WO2004/66997 A2, ; Page/Page column 46-47 ; |
|
~%
124751-00-4 |
| Literature: US5298517 A1, ; US 5298517 A |
|
~95%
124751-00-4 |
| Literature: Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 54, # 12 p. 754 - 757 |
|
~33%
124751-00-4 |
| Literature: EP1833801 B1, ; Page/Page column 14 ; |
|
~%
124751-00-4 |
| Literature: WO2006/38223 A1, ; Page/Page column 6-7 ; |
|
~%
124751-00-4 |
| Literature: EP1833801 B1, ; Page/Page column 14 ; |
|
~68%
124751-00-4 |
| Literature: WO2006/81807 A2, ; Page/Page column 16; 18; 20; 28-29 ; |
| Precursor 9 | |
|---|---|
| DownStream 4 | |